Clinical Trial Update: Rituximab for ANCA-associated Vasculitis (RAVE) Long-Term Follow-Up Study

View source ↗

Summary

This clinical trial update reports long-term follow-up results from the RAVE study evaluating rituximab for ANCA-associated vasculitis, including granulomatosis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatosis with Polyangiitis
• Microscopic Polyangiitis

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Johns Hopkins University | Conditions: Granulomatosis With Polyangiitis, Microscopic Polyangiitis | Status: TERMINATED